1. Home
  2. CYCC vs BAOS Comparison

CYCC vs BAOS Comparison

Compare CYCC & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • BAOS
  • Stock Information
  • Founded
  • CYCC 1992
  • BAOS 2018
  • Country
  • CYCC United States
  • BAOS China
  • Employees
  • CYCC N/A
  • BAOS N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • BAOS Business Services
  • Sector
  • CYCC Health Care
  • BAOS Consumer Discretionary
  • Exchange
  • CYCC Nasdaq
  • BAOS Nasdaq
  • Market Cap
  • CYCC 3.6M
  • BAOS 4.0M
  • IPO Year
  • CYCC N/A
  • BAOS 2021
  • Fundamental
  • Price
  • CYCC $0.25
  • BAOS $2.08
  • Analyst Decision
  • CYCC Strong Buy
  • BAOS
  • Analyst Count
  • CYCC 1
  • BAOS 0
  • Target Price
  • CYCC $11.00
  • BAOS N/A
  • AVG Volume (30 Days)
  • CYCC 160.2K
  • BAOS 273.7K
  • Earning Date
  • CYCC 05-13-2025
  • BAOS 05-14-2025
  • Dividend Yield
  • CYCC N/A
  • BAOS N/A
  • EPS Growth
  • CYCC N/A
  • BAOS N/A
  • EPS
  • CYCC N/A
  • BAOS N/A
  • Revenue
  • CYCC $74,000.00
  • BAOS $859,226.00
  • Revenue This Year
  • CYCC N/A
  • BAOS N/A
  • Revenue Next Year
  • CYCC $88.68
  • BAOS N/A
  • P/E Ratio
  • CYCC N/A
  • BAOS N/A
  • Revenue Growth
  • CYCC N/A
  • BAOS N/A
  • 52 Week Low
  • CYCC $0.22
  • BAOS $1.44
  • 52 Week High
  • CYCC $4.00
  • BAOS $13.66
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 29.30
  • BAOS 40.86
  • Support Level
  • CYCC $0.29
  • BAOS $2.02
  • Resistance Level
  • CYCC $0.32
  • BAOS $2.66
  • Average True Range (ATR)
  • CYCC 0.02
  • BAOS 0.40
  • MACD
  • CYCC -0.00
  • BAOS 0.01
  • Stochastic Oscillator
  • CYCC 19.92
  • BAOS 18.27

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original big data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.

Share on Social Networks: